[Disputable issues of anticoagulant therapy: exacerbation of coronary heart disease and transcutaneous interventions in patients with cardiac fibrillation treated with vitamin K antagonists].
The article concerns the policy of anti-platelet treatment in patients with coronary heart disease exposed to transcutaneous coronary interventions. Patients with cardiac fibrillations are specially considered. International trials are reviewed.
Iavelov
I S
IS
D054058:Acute Coronary Syndrome / Q000000981:diagnostic imaging / Q000209:etiology / Q000517:prevention & control*; D000925:Anticoagulants / Q000008:administration & dosage*; D001145:Arrhythmias, Cardiac / Q000150:complications*; D000075202:Contraindications; D017023:Coronary Angiography; D054059:Coronary Occlusion / Q000000981:diagnostic imaging / Q000209:etiology / Q000517:prevention & control*; D003328:Coronary Thrombosis / Q000000981:diagnostic imaging / Q000209:etiology / Q000517:prevention & control*; D018450:Disease Progression; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D015607:Stents; D014812:Vitamin K / Q000037:antagonists & inhibitors*; D014859:Warfarin / Q000008:administration & dosage*
D000925:Anticoagulants; D014812:Vitamin K; D014859:Warfarin